Latest Sanofi-Aventis Stories
PARIS, June 29, 2011 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that it entered into a research collaboration with Weill Cornell Medical College to develop new anti-infectives that aim to shorten the course of treatment of tuberculosis (TB) and provide effective therapies against drug-susceptible and drug-resistant strains of TB. (Logo: http://photos.prnewswire.com/prnh/20110616/NY20158LOGO ) Under the terms of the collaboration, Sanofi will provide 80,000 chemical...
SWIFTWATER, Pa., June 28, 2011 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), offers its congratulations to the four winners of the International BioGENEius Challenge, a competition for high school students who demonstrate an exemplary understanding of biotechnology through science research projects. Sanofi Pasteur has sponsored the International BioGENEius Challenge since its inception in the early 1990s.
Strategic Canadian asset puts Ontario at the heart of global vaccine innovation To view the Social Media Release, click here: http://smr.newswire.ca/en/sanofi-pasteur/sanofi-pasteur-opens-100m-rd-centre-in-canada TORONTO, June 22, 2011 /PRNewswire/ - Mark Lievonen, President of Sanofi Pasteur Limited, and Premier Dalton McGuinty today opened a $101 million dollar vaccine research and development facility at Sanofi Pasteur's Connaught Campus in north Toronto.
FRANKLIN LAKES, N.J., June 22, 2011 /PRNewswire/ -- Sanofi (NYSE: SNY), Medco Health Solutions, Inc.
CHICAGO, June 17, 2011 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.
PARIS, June 16, 2011 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that it has entered into a two-year research collaboration with the biopharmaceutical company Audion Therapeutics (Audion) to develop potential treatments for hearing loss through the optimization of small molecules by using a regenerative medicine approach. (Logo: http://photos.prnewswire.com/prnh/20110616/NY20158LOGO ) This collaborative research will utilize technology developed at the Massachusetts...
ALLEGAN, Mich., June 15, 2011 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that its partner Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) (previously Barr Laboratories Inc.) has begun shipping Triamcinolone Acetonide Nasal Spray.
Robert Storey, Professor of Cardiology at the University of Sheffield's Department of Cardiovascular Science, presented findings today that confirm one in five deaths in the year following a heart attack could be prevented if a new drug, ticagrelor, was used instead of the standard treatment, clopidogrel.
BRIDGEWATER, N.J., June 7, 2011 /PRNewswire/ -- Actors Paul and Mira Sorvino today announce the Diabetes Co-Stars: Cook-Off. This nationwide recipe contest runs from June 7-July 20, 2011 and is a continuation of their work with sanofi-aventis U.S.
PARIS and TARRYTOWN, N.Y., June 6, 2011 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc.
- The act of sweetening by admixture of some saccharine substance.